Amelia Melas

Associate

Overview

Amelia Melas is a skilled attorney whose practice focuses on drafting, negotiating, and advising life sciences clients on a wide range of agreements necessary to advance their products through research and development, including clinical trial-related contracts.

Previously, Amelia worked in-house at a large health insurance company and at a health care provider on matters related to health care regulation.

In law school, Amelia was a Managing Editor for the American Journal of Law & Medicine, one of the country’s leading health law journals, where she also published a paper.

Career & Education

    • Legal Intern, Trillium Health
    • Legal Intern, Blue Cross Blue Shield of Massachusetts
    • Legal Intern, Trillium Health
    • Legal Intern, Blue Cross Blue Shield of Massachusetts
    • Georgia Institute of Technology, B.S.
    • Boston University School of Law, J.D.
    • Georgia Institute of Technology, B.S.
    • Boston University School of Law, J.D.
    • Massachusetts
    • Massachusetts

Representative Matters

  • Supported multiple companies with multi-center clinical trials in the U.S. and internationally by developing custom clinical trial agreement templates, drafting and negotiating clinical trial site and related contracts, and providing project management coordination. Recent studies include:
      • Two Phase 2 clinical trials of a product treating heart failure involving approximately 600 patients across 175 sites in North America, Europe, Asia, and Australia;
      • A Phase 1/2 clinical trial of an investigational product in combination with standard-of-care treatments for various cancers in over 600 patients at approximately 60 sites in North America and Europe; and
      • The first-in-human clinical trial of an antibody-drug conjugate targeting cancer in over 250 patients in North America for a leading biotechnology company.
  • Drafted and negotiated agreements with service providers for clinical and preclinical studies of therapeutic and medical device products, including master services agreements with large, multinational contract research organizations valued at over $10 million.

Practices